What is Biohaven's other current assets?

Biohaven (BHVN) reported other current assets of $3.17M in Q1 2026.

How has Biohaven's other current assets changed year-over-year?

Biohaven's other current assets decreased by 12.5% year-over-year, from $3.62M to $3.17M.

What is the long-term trend for Biohaven's other current assets?

Over 4 years (2021 to 2025), Biohaven's other current assets has grown at a 0.6% compound annual growth rate (CAGR), from $2.12M to $2.17M.

Biohaven BHVN Other current assets

Other current assets at other companies

Eli LillyLLY

——

Roivant SciencesROIV

——

BiogenBIIB

——

TG TherapeuticsTGTX

——

ImmunityBio, Inc.IBRX

——

Other financials

Income statement

See full

Operating income-$130.4M+41.1%

Net income-$130.5M+41.1%

EPS (diluted)-$0.88+59.4%

Balance sheet

See full

Cash & equivalents$277.1M+170%

Total debt$286.2M+706%

Total equity$129.5M-50.1%

Total assets$466.4M+1.6%

Cash flow

See full

Operating cash flow-$149.9M+9.2%

CapEx--100%

Free cash flow-$149.9M+9.5%

Valuation

See full

Market cap$2.25B-48.1%

Returns & leverage

See full

Return on equity-333%+17.9pp

Debt / equity2.2×+2.1×

Current ratio7.4×+5.1×

Where this comes from

Reported directly by Biohaven in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsCurrent.

The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biohaven's other current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Biohaven's other current assets?: Biohaven (BHVN) reported other current assets of $3.17M in Q1 2026.
How has Biohaven's other current assets changed year-over-year?: Biohaven's other current assets decreased by 12.5% year-over-year, from $3.62M to $3.17M.
What is the long-term trend for Biohaven's other current assets?: Over 4 years (2021 to 2025), Biohaven's other current assets has grown at a 0.6% compound annual growth rate (CAGR), from $2.12M to $2.17M.